SHINE Medical Technologies has chosen Janesville as the location for a new manufacturing plant.
The Middleton-based company says the new plant is expected to create more than 100 permanent jobs when it opens in 2015.
SHINE says the new plant is intended to help the company become the first large-scale domestic supplier of molybdenum-99 (meh-LIB'-deh-nem-99), a medical isotope.
Moly-99 is primarily used for detecting heart disease and determining the stage of cancer progression. Historically, most moly-99 used in the U.S. has been produced in Canada and the Netherlands using highly enriched uranium placed in research reactors. But unscheduled shutdowns of the reactors in 2009 and 2010 caused worldwide shortages of moly-99.
SHINE says its Janesville plant will produce enough moly-99 for about 10 million diagnostic and treatment procedures each year.